ABBOTT INDIA LIMITED
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2011-04-11
- Lead Sponsor
- Abbott
- Target Recruit Count
- 309
- Registration Number
- NCT00235872
Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2011-04-11
- Lead Sponsor
- Abbott
- Target Recruit Count
- 25
- Registration Number
- NCT00235833
Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2007-08-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 128
- Registration Number
- NCT00235859
Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2007-08-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 445
- Registration Number
- NCT00235885
- Locations
- 🇺🇸
Global Medical Information - Abbott, Abbott Park, Illinois, United States
Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2008-07-17
- Lead Sponsor
- Abbott
- Target Recruit Count
- 271
- Registration Number
- NCT00235820
- Locations
- 🇺🇸
Global Medical Information-Abbott, Abbott Park, Illinois, United States
Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2007-08-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 148
- Registration Number
- NCT00234845
- Locations
- 🇺🇸
Global Medical Information - Abbott, Abbott Park, Illinois, United States
Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2008-07-10
- Lead Sponsor
- Abbott
- Target Recruit Count
- 152
- Registration Number
- NCT00234910
- Locations
- 🇺🇸
Global Medical Information-Abbott, Abbott Park, Illinois, United States
Post-marketing Observational Study in Subjects With Rheumatoid Arthritis
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2011-09-30
- Lead Sponsor
- Abbott
- Target Recruit Count
- 3435
- Registration Number
- NCT00234884
- Locations
- 🇬🇷
Site Ref # / Investigator 26425, Patras, Greece
🇧🇪Site Ref # / Investigator 49810, Hasselt, Belgium
🇧🇪Site Ref # / Investigator 49814, Hasselt, Belgium
A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2008-07-15
- Lead Sponsor
- Abbott
- Target Recruit Count
- 1204
- Registration Number
- NCT00235014
A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2010-05-11
- Lead Sponsor
- Abbott
- Target Recruit Count
- 10777
- Registration Number
- NCT00234832
- Locations
- 🇺🇸
Global Medical Services, North Chicago, Illinois, United States
© Copyright 2024. All Rights Reserved by MedPath